- INFORMACIÓN DE SALUD
- OBTENGA APOYO
- representación del paciente
Katie Rielly-Gauvin brings more than 20 years of a broad range of business experiences in the pharmaceutical industry. Ms. Rielly-Gauvin is currently Vice President of Global Commercial Development at AbbVie, a global biopharmaceutical company, where she is responsible for developing the strategic marketing direction of key compounds in AbbVie's pipeline across key Therapeutic areas in Immunology, Oncology, Neuroscience and Renal Care. Prior to joining AbbVie, Ms. Rielly-Gauvin was at Johnson & Johnson where her last role was Vice President, Redscript Ventures, a Johnson & Johnson business accelerator created purposely for shaping new, venture stage business investments. Prior to this role, Ms. Rielly-Gauvin was Vice President of Sales & Marketing for the Janssen Commercial CNS organization, where she was responsible for a $3.0B product portfolio. Ms. Rielly-Gauvin began her career at Johnson & Johnson family of companies in 1993, where she worked as Manager of Infectious Disease Research at Ortho-McNeil and held positions of increasing responsibility in Medical Affairs and the Commercial organizations. She began her career with Bristol-Myers Squibb as a Research Scientist in clinical drug development. Ms. Rielly-Gauvin holds a Bachelor of Science degree in Chemistry from Simmons College and an MBA in Economics from Rutgers University. She is an outside board member of the Family Guidance Center and resides in the Northern suburbs of Chicago with her husband and two children. Ms. Rielly-Gauvin has served on the Preeclampsia Foundation board since 2011.
Beth Frazer received a Juris Doctrate from the University of Louisville Brandeis School of Law. She practiced as a civil litigator, representing clients both in and out of court on a variety of matters including employment disputes and civil rights claims. Ms. Frazer began her involvement with the Preeclampsia Foundation in 2008 after experiencing HELLP Syndrome when 20 weeks pregnant, which resulted in the death of her twins. She and her husband, Bryan, live in Nashville, Tenn. with their son and daughter, and currently serve as co-coordinators of the Nashville Promise Walk for Preeclampsia. Ms. Frazer has served on the Preeclampsia Foundation board since 2013.
Linda J. Murray is the Senior Vice President of Editorial and Global Editor in Chief of BabyCenter.com, the #1 parenting and pregnancy digital resource around the world. She has addressed a variety of parenting topics on national television. Her numerous appearances include: "Dr. Phil"; "Anderson"; "20/20"; NBC-TV's "Today"; CBS-TV's "The Early Show"; "Access Hollywood"; "Extra"; CNN; ABC-TV's "Good Morning America" and MSNBC. Ms. Murray has represented the voice of American mothers at national summits including a post-State of the Union education roundtable at The White House. And she has written on the state of global Motherhood for The Huffington Post. Linda is co-author of The BabyCenter Essential Guide to Pregnancy and Birth and The BabyCenter Essential Guide to Your Baby's First Year. She is also the editor of two new books, BabyCenter Pregnancy: From Preconception to Birth, and BabyCenter Baby: The All Important First Year (DK Publishing, August 2010). Prior to joining BabyCenter, Linda was a Senior Editor at Child magazine where she specialized in the subjects of children's health and safety. Her career also included editing positions at Redbook, Self, and Cosmopolitan magazines, and a producing role on the public television program, "The Open Mind." A transplanted New Yorker, Linda now lives in the Bay Area with her family where she enjoys horseback riding with her daughter in her free time. Ms. Murray has served on the Board since 2013.
Richard C. Proctor, Jr., is the Managing Partner of Breakthrough Life Sciences, a consulting firm specializing in business development and strategy. Previously, Mr. Proctor was the Chief Executive Officer of Glenveigh Medical, a biotech company focused on maternal-fetal medicine. Glenveigh is developing a new therapeutic for severe preeclampsia. Mr. Proctor joined Glenveigh in 2005 after 14 years with GlaxoSmithKline in Research Triangle Park, North Carolina, including Director of US Business Development and Lifecycle Marketing. He was also the investment manager for the Glaxo Wellcome charitable foundation. His background includes senior roles in project management, business development, marketing, and corporate finance. He attended Darlington School, Emory University (BBA), Wake Forest University (MBA), and has received many awards for his scholarship, leadership, and career success. Mr. Proctor is returning to the Preeclampsia Foundation Board of Directors after serving previously from 2007 to 2012.
S. Kerry Tassopoulos is Vice-President, Government Relations and Compliance at Mary Kay Inc., a Dallas, Texas based manufacturer and distributor of cosmetics and personal care products. He is involved in every aspect of the Company’s government relations efforts at the state, federal and international levels. He has led the Company’s public affairs efforts in the European Union, and is currently focused on federal legislative and regulatory matters. Kerry also is responsible for overseeing the Company’s Risk Management and Knowledge Resources Departments. During his 20 year career at Mary Kay, Kerry has provided legal advice to his Mary Kay colleagues on a wide range of issues, including international, federal and state regulatory matters and the manufacture, distribution and marketing of Mary Kay products. He has additional public affairs and government relations experience, gained while Director, Government Affairs at Excel Communications, a direct seller of long distance and telecommunications products, from 1996-2001. Kerry currently is Vice Chairman of the Direct Selling Education Foundation (DSEF), a member of the Government Relations Committees of both the US Direct Selling Association and the Personal Care Products Council (PCPC), and on the Regulatory Affairs Committee of the World Federation of Direct Selling Associations. He also serves on the Board of Directors of the Public Affairs Council, the Executive Committee of the Dallas Committee on Foreign Relations and the Board of the Dallas Convention and Visitors Bureau. He received his B.A. from Emory University in 1979 and his J.D. from the University Of Georgia School Of Law in 1985. Kerry and his wife Katina live in Dallas, Texas and have three adult children – Harrison, Cynthia and Alexander.
Kathy Maguire holds a Master's Degree in early childhood leadership and advocacy, with 20 years' experience in early childhood education. Most recently she worked as a Program Associate and Consultant to child care centers and elementary schools with an emphasis on continuous quality improvement and accreditation attainment. Ms. Maguire began volunteering with the Preeclampsia Foundation in January 2006 after experiencing preeclampsia, which resulted in her daughter's premature birth at 29 weeks. She served as the Director of Volunteer Development, National Walk-a-thon chair, and was honored as the 2007 Preeclampsia Foundation Volunteer of the Year. Currently she is a stay-at-home mom and lives with her husband and daughter in Indiana. Ms. Maguire has served on the Preeclampsia Foundation board since 2011.
Matthew Cooper is currently the CEO and Founder of Carmenta Bioscience, a company developing diagnostic tests for preeclampsia spun out of Stanford School of Medicine in 2012. Matthew's passion for addressing unmet medical needs in preeclampsia is a direct result of almost losing his wife during the birth of his son to this horrible syndrome. Matthew has over 15 years experience in biomarker and drug development across all stages of development. He started his career at Biogen Idec and was subsequently recruited to Roche, where he ultimately assumed the role of Global Head of Non-clinical Safety Information. Matthew has also served in leadership roles in miscellaneous industry consortia, including the Chair of the Data Analysis and Management Working Group for the Predictive Safety Testing Consortium (PSTC) at the Critical Path Institute. He recently earned dual MBAs from Columbia Business School and the Berkeley Haas School of Business. He is board certified in toxicology (Diplomat of the American Board of Toxicology) and has earned a Certificate of Entrepreneurship from the Berkeley Haas School of Business. Matthew advises start-ups in the healthcare and healthcare IT spaces and is currently a mentor for the Business Association of Stanford Entrepreneurial Students, Berkeley Haas School of Business, and UCSF Lean LaunchPad for the Life Sciences. He joined the Board in 2014.
John D. Jacobson, MD, became a supporter of the Foundation while seeking an understanding of preeclampsia after the mother of his granddaughter died of complications of HELLP Syndrome in 2005. Dr. Jacobson received his medical degree from the University of Washington. Before returning to Seattle for his anesthesia residency, he served as a flight surgeon in the United States Air Force with assignments to Viet Nam and England. He recently retired from his anesthesia practice at Eisenhower Memorial Hospital in Rancho Mirage, California. He resides with his wife, Karen, in Palm Desert, CA. They have three sons and five, soon to be six, grandchildren. Dr. Jacobson has served on the Board since 2013.
Estos artículos son sólo en Inglés